Received Apr 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
had not completed the series yet; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose anywhere between 2 to 5 years ago). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: had not completed the series yet). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 16-APR-2025 An office manager informed that a patient had gotten the first dose of Shingrix vaccine anywhere between 2 to 5 years ago and had not completed the series yet at the moment of the call. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination.